PT1765807E - Formas sólidas do sal de magnésio de (s)-omeprazole e processos para a sua preparação - Google Patents

Formas sólidas do sal de magnésio de (s)-omeprazole e processos para a sua preparação Download PDF

Info

Publication number
PT1765807E
PT1765807E PT05760736T PT05760736T PT1765807E PT 1765807 E PT1765807 E PT 1765807E PT 05760736 T PT05760736 T PT 05760736T PT 05760736 T PT05760736 T PT 05760736T PT 1765807 E PT1765807 E PT 1765807E
Authority
PT
Portugal
Prior art keywords
omeprazole
magnesium salt
solid forms
preparation
solvent
Prior art date
Application number
PT05760736T
Other languages
English (en)
Portuguese (pt)
Inventor
Laura Coppi
Ramon Berenguer Maimo
Yolanda Gasanz Guillen
Jorge Medrano Ruperez
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of PT1765807E publication Critical patent/PT1765807E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT05760736T 2004-07-02 2005-06-29 Formas sólidas do sal de magnésio de (s)-omeprazole e processos para a sua preparação PT1765807E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200401729A ES2246149B1 (es) 2004-07-02 2004-07-02 Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.

Publications (1)

Publication Number Publication Date
PT1765807E true PT1765807E (pt) 2009-04-13

Family

ID=34972307

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05760736T PT1765807E (pt) 2004-07-02 2005-06-29 Formas sólidas do sal de magnésio de (s)-omeprazole e processos para a sua preparação

Country Status (19)

Country Link
US (1) US7902370B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1765807B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP5575366B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR101290035B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1976923B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE425975T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2005259205B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2570559C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1109048T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE602005013382D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1765807T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2246149B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20090211T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA06014736A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO20070635L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ552458A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1765807E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2006003163A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200700865B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
HUT75775A (en) * 1994-07-08 1997-05-28 Astra Ab Medicament with multiple unit tablated dosage form containing omeprazole
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
SI20974A (sl) * 1999-08-26 2003-02-28 Aaipharma, Inc. Alkoksi substituirane benzimidazolne spojine, farmacevtski pripravki, ki jih vsebujejo ter metode za njihovo uporabo
US6312712B1 (en) * 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
CN1437593A (zh) 2000-05-15 2003-08-20 兰贝克赛实验室有限公司 新颖的无定形奥美拉唑盐
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
CA2775616C (en) * 2000-08-04 2013-09-17 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
US7612098B2 (en) * 2002-08-30 2009-11-03 Dr. Reddy's Laboratories Limited Amorphous hydrous esomeprazole magnesium
CN1728997A (zh) * 2002-10-22 2006-02-01 兰贝克赛实验室有限公司 (es)奥美拉唑的无定形盐
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
WO2004089935A1 (en) * 2003-04-10 2004-10-21 Hetero Drugs Limitd Novel crystalline forms of s-omeprazole magnesium
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.

Also Published As

Publication number Publication date
ES2246149B1 (es) 2007-06-01
EP1765807B1 (en) 2009-03-18
CA2570559A1 (en) 2006-01-12
US7902370B2 (en) 2011-03-08
NZ552458A (en) 2010-07-30
MXPA06014736A (es) 2007-06-25
KR101290035B1 (ko) 2013-07-30
DK1765807T3 (da) 2009-06-08
JP2014169302A (ja) 2014-09-18
CN1976923B (zh) 2011-08-24
CN1976923A (zh) 2007-06-06
JP2008505160A (ja) 2008-02-21
WO2006003163A1 (en) 2006-01-12
AU2005259205B2 (en) 2011-01-27
DE602005013382D1 (de) 2009-04-30
US20070249684A1 (en) 2007-10-25
ZA200700865B (en) 2009-09-30
KR20070031992A (ko) 2007-03-20
AU2005259205A1 (en) 2006-01-12
CA2570559C (en) 2012-08-28
ATE425975T1 (de) 2009-04-15
CY1109048T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2014-07-02
HRP20090211T1 (en) 2009-05-31
ES2323319T3 (es) 2009-07-13
EP1765807A1 (en) 2007-03-28
ES2246149A1 (es) 2006-02-01
NO20070635L (no) 2007-03-20
JP5575366B2 (ja) 2014-08-20

Similar Documents

Publication Publication Date Title
DK1073694T3 (da) Trans-xanthophyllesterkoncentrater med forøget renhed og fremgangsmåder til fremstilling af samme
UA109774C2 (uk) Кристалічні форми саксагліптину та процес його одержання (варіанти)
HU229514B1 (en) 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Reddy et al. Highly stereoselective cyclopropanation of glycals with cyclic diazoamides: a facile synthesis of spirooxindolyl sugar derivatives
Chavan et al. Efficient and mild method for preparation of allylic amines from aziridine-2-alcohols using PPh3/I2/imidazole
WO2007054964A3 (en) Process for the preparation of letrozole
EA200601742A1 (ru) Усовершенствованный способ производства хлорированной сахарозы
ES8105315A1 (es) Un procedimiento para la preparacion de 5'-deoxi-5-fluo- rouridina
ATE332297T1 (de) Verfahren zur herstellung von ascorbinsäure
ZA200700865B (en) Solid forms of the magnesium salt of (S)-omeprazole and processes for their preparation
DE50104094D1 (de) Verfahren zur Herstellung von reinem Triethylendiamin (TEDA)
ZA200600012B (en) Process for preparing maltitol enriched products
UA95781C2 (en) Process of preparing bromopicrin
CN107474021B (zh) 噁二嗪衍生物及其制备方法和应用
EP1331215A4 (en) METHOD FOR SEPARATING REACTION PRODUCTS FROM CATALYSTS
WO2007092705A3 (en) Process for preparing gemcitabine and associated intermediates
Hu et al. Direct stereoselective construction of cyclopropane α-amino acid with contiguous quaternary centers via [4+ 2] annulation reaction
DE69838686T2 (de) Tripeptidylpeptidaseinhibitoren
WO2007070238A3 (en) Processes for the preparation of modafinil and analogs thereof
Yamanaka et al. An efficient synthesis of the orally-active GpIIb/IIIa antagonist FR184764
de Saint-Fuscien et al. A new straightforward synthesis of 2, 3-aziridino-γ-lactones
DE502005004950D1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
ES2439322T3 (es) Derivados de amino alcohol y sus actividades terapéuticas
ES2263824T3 (es) Metodo para la produccion de una sustancia fenolica a partir de madera.
Maougal et al. An Efficient Synthesis of 3, 3′-Bipiperidines Using an ROM/RCM Metathesis Sequence: Extension to Oxygenated Analogues